Publications

Case Reports
Journal Article Research Support, Non-U.S. Gov't
Epublish 77 citations
Electronic publication date
January 19, 2016

View on Pubmed.gov 25915946 | View on doi.org 10.1371/journal...

Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors.

Search for publications in this journal PLoS One - 10(4):e0123092

Abstract

BACKGROUND

PIK3CA-related overgrowth spectrum (PROS) include a group of disorders that affect only the terminal portion of a limb, such as type I macrodactyly, and conditions like fibroadipose overgrowth (FAO), megalencephaly-capillary malformation (MCAP) syndrome, congenital lipomatous asymmetric overgrowth of the trunk, lymphatic, capillary, venous, and combined-type vascular malformations, epidermal nevi, skeletal and spinal anomalies (CLOVES) syndrome and Hemihyperplasia Multiple Lipomatosis (HHML). Heterozygous postzygotic PIK3CA mutations are frequently identified in these syndromes, while timing and tissue specificity of the mutational event are likely responsible for the extreme phenotypic variability observed.

METHODS

We carried out a combination of Sanger sequencing and targeted deep sequencing of genes involved in the PI3K/AKT/mTOR pathway in three patients (1 MCAP and 2 FAO) to identify causative mutations, and performed immunoblot analyses to assay the phosphorylation status of AKT and P70S6K in affected dermal fibroblasts. In addition, we evaluated their ability to grow in the absence of serum and their response to the PI3K inhibitors wortmannin and LY294002 in vitro.

RESULTS AND CONCLUSION

Our data indicate that patients' cells showed constitutive activation of the PI3K/Akt pathway. Of note, PI3K pharmacological blockade resulted in a significant reduction of the proliferation rate in culture, suggesting that inhibition of PI3K might prove beneficial in future therapies for PROS patients.

References

Am J Med Genet. 1998 Oct 2;79(4):311-8

Am J Hum Genet. 2012 Jun 8;90(6):1108-15

Hum Mol Genet. 2015 Feb 15;24(4):926-38

Nat Genet. 2014 May;46(5):510-5

Cited by 77 citations (total)

Journal Article Review

Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway.

Electronic publication date April 26, 2017

Search for publications in this journal Dermatol Clin

Neera Nathan [...] Thomas N Darling et al.

Somatic mutations in genes of the PI3K/PTEN/AKT/TSC/mTORC1 signaling pathway cause segmental overgrowth, hamartomas, and malignant tumors. Mosaicism for activating mutations...

Journal Article Review

Neurocutaneous Manifestations of Genetic Mosaicism.

Electronic publication date September 13, 2016

Search for publications in this journal J Pediatr Genet

Maurice A M van Steensel

Genetic mosaicism is defined as the presence of two or more genetically distinct cell populations in a single individual. Ever...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances